Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
Isis Pharmaceuticals, Inc. (NQ: ISIS)
20.33 USD  -0.06 (-0.29%)
Streaming Delayed Price  /  Updated: 9:50 AM EDT, May 23, 2013  /  Add to My Watchlist      
View: Quote News Research
Stories about Isis Pharmaceuticals, Inc.
 
< Previous 1 2
...
5 6 7 8 9 10 11 12 13
...
15 16 Next >
Pfizer (PFE) Completes Excaliard Acquisition
December 02, 2011
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=6990751 for the full story. Read More
from StreetInsider.com News Articles
Isis (ISIS) Will Get Up to $14M in Pfizer's (PFE) Acquisition of Excaliard Pharma
November 22, 2011
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=6969326 for the full story. Read More
from StreetInsider.com News Articles
Jefferies Cuts Price Targets on ISIS Pharmaceuticals (ISIS), Has Enough Cash Through 2014
November 08, 2011
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=6925711 for the full story. Read More
from StreetInsider.com News Articles
Isis Pharmaceuticals Crosses Below its 10-day MA (ISIS)
November 08, 2011
from Comtex SmarTrend® News Briefs
Isis Pharmaceuticals, Inc. (ISIS) Posts Q3 Loss of $0.27, Sales Miss Expectations
November 07, 2011
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=6921856 for the full story. Read More
from StreetInsider.com News Articles
Trading Radar for 11/04: DISH Network (DISH), Sysco (SYY), EnerNOC (ENOC), Priceline.com (PCLN) Report
November 04, 2011
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=6916745 for the full story. Read More
from StreetInsider.com News Articles
Isis Pharmaceuticals (ISIS) Initiates Phase 1 Clinical Studies for ISIS-GCGRRx and ISIS-GCCRRx
November 02, 2011
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=6904303 for the full story. Read More
from StreetInsider.com News Articles
Isis Pharma (ISIS) Says Santaris Pharma Infringed on Patents, Files Lawsuit
September 23, 2011
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=6807305 for the full story. Read More
from StreetInsider.com News Articles
BMO Starts Biotech Stocks: AMGN, HGSI, REGN, CELG at Outperform, AMLN, GILD, ARNA at Market Perform, BIIB at Underperform
September 07, 2011
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=6769779 for the full story. Read More
from StreetInsider.com News Articles
XOMA Rearranges The Deck Chairs One More Time (XOMA, REGN, PFE, ABT, ISIS, VICL, CELG)
September 02, 2011
XOMA changes management again, but should anybody care? Read More
from Investopedia Advisor Commentary
Separate paths lead to promising cholesterol drug
August 26, 2011
NEW YORK, Aug 26 (Reuters) - Discovery of one of the most promising cholesterol fighters in decades began in 1999 with Catherine Boileau, a Paris scientist who was seeking a genetic reason why 19... Read More
category companyNews
from Reuters: Company News
Previous 52-Week Low Surpassed in Shares of Isis Pharmaceuticals (ISIS)
August 11, 2011
from Comtex SmarTrend® News Briefs
Needham & Company Maintains a 'Hold' on ISIS Pharmaceuticals (ISIS); 2Q11/Early 3Q11 Review - Mipomersen Application in EU (Submitted) and US (Expected by YE11)
August 08, 2011
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=6693106 for the full story. Read More
from StreetInsider.com News Articles
Isis Pharmaceuticals, Inc. (ISIS) Posts Q2 EPS Loss of $0.18
August 04, 2011
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=6688802 for the full story. Read More
from StreetInsider.com News Articles
Sanofi Sales Helped by Genzyme
July 28, 2011
Sanofi’s (SNY) earnings announcement today is a mixed bag of news. And you don’t have to be a Sanofi investor to be on the receiving end. First former Genzyme investors who held on to a tracking stock... Read More
from Minyanville Headlines
Genzyme Submits NDA for Mipomersen to EMA; Select Kynamro as Brand Name (SNY) (ISIS)
July 28, 2011
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=6665838 for the full story. Read More
from StreetInsider.com News Articles
6.5% Return Seen to Date on SmarTrend Isis Pharmaceuticals Call (ISIS)
July 26, 2011
from Comtex SmarTrend® News Briefs
Isis Pharmaceuticals (ISIS) Initiates Phase 1 Study for ISIS-PTP1BRx
July 21, 2011
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=6650673 for the full story. Read More
from StreetInsider.com News Articles
Bristol-Myers, AstraZeneca Dealt Setback on Diabetes Drug
July 20, 2011
It shouldn’t come as a big surprise that Bristol-Myers Squibb (BMY) and AstraZeneca (AZN) failed to win over a panel of government medical experts considering an experimental diabetes drug... Read More
from Minyanville Headlines
SmarTrend Watching for Potential Rebound in Shares of Isis Pharmaceuticals After 0.11% Loss (ISIS)
July 20, 2011
from Comtex SmarTrend® News Briefs
Watch for Isis Pharmaceuticals to Potentially Rebound after Falling 2.90% Yesterday (ISIS)
July 06, 2011
from Comtex SmarTrend® News Briefs
Global Hunter Securities Starts Aegerion Pharmaceuticals (AEGR) at Buy; Lomitapide – A Potential Best-in-Class Drug
June 28, 2011
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=6605338 for the full story. Read More
from StreetInsider.com News Articles
6.2% Return Seen to Date on SmarTrend Isis Pharmaceuticals Call (ISIS)
June 18, 2011
from Comtex SmarTrend® News Briefs
After Yesterday's Decline of 0.90%, Isis Pharmaceuticals Offers Investors Better Value (ISIS)
June 15, 2011
from Comtex SmarTrend® News Briefs
SmarTrend Vindicated on Isis Pharmaceuticals Downtrend Call: Stock Price Down 4.2% (ISIS)
June 10, 2011
from Comtex SmarTrend® News Briefs
Isis Pharmaceuticals Has Returned 4.5% Since SmarTrend Recommendation (ISIS)
May 31, 2011
from Comtex SmarTrend® News Briefs
Isis Pharmaceuticals Earnings In Retrospect: Down 2.03% In Last 15 Days (ISIS)
May 23, 2011
from Comtex SmarTrend® News Briefs
Isis Pharma (ISIS) Initiates ISIS-TTRRx Phase I; Receives $5M Milestone from Glaxo (GSK)
May 19, 2011
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=6520982 for the full story. Read More
from StreetInsider.com News Articles
Isis Pharmaceutical (ISIS) Earns $3 Million Payment from GlaxoSmithKline (GSK)
May 16, 2011
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=6506314 for the full story. Read More
from StreetInsider.com News Articles
Isis Pharmaceuticals, Inc. (ISIS) Falls Short of Q1 Views
May 06, 2011
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=6479733 for the full story. Read More
from StreetInsider.com News Articles
< Previous 1 2
...
5 6 7 8 9 10 11 12 13
...
15 16 Next >
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here